Phase 1 dose-finding study of Irinotecan to reduce systemic inflammation in COVID-19
- Funded by National Medical Research Council Singapore
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
National Medical Research Council SingaporePrincipal Investigator
Anand JeyasekharanResearch Location
SingaporeLead Research Institution
NUH SingaporeResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified